Altitude Hypoxia

4

Review clinical trials related to Altitude Hypoxia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Altitude and Outcomes in Pediatric ARDS: A Multicenter Study

This multicenter observational study will evaluate the association between geographic altitude, availability of critical care resources, and clinical outcomes in children with pediatric acute respiratory distress syndrome (PARDS). Data on demographics, physiology, and hospital structure will be collected from PICUs located at different altitudes worldwide. The study aims to identify gaps in PARDS management and provide recommendations adapted to diverse resource settings.

Participants needed: 1,600
Trial details
Age: 1-18Biological sex: AllType: ObservationalSponsor: Latin American Pediatric Collaborative NetworkUpdated: Jun 2, 2026Locations: 20
Eligibility criteria

Age between 1 month (corrected gestational age) and 18 years. [+3]

Patients with active perinatal lung disease (e.g., neonatal respiratory distress... [+3]

Status: Not yet recruiting

Study of the Effects of Acute Exposure to Moderate Altitude Hypoxia on Prospective Memory.

The goal of this study is to investigate whether prospective memory, i.e., memory for delayed intentions, is impaired at moderate altitude (4,000m). It will also allow to study the effect of air and oxygen administration during hypoxia exposure. The main questions it aims to answer are: * Does moderate acute hypoxia impair prospective memory ? * If so, does air or oxygen adminsitration induce a restoration of prospective memory? Researchers will compare cognitive performance during normobaric hypoxia exposure to cognitive performance during normoxia (control situation). Participants will: * Session S0. Perform a battery of neuropsychological tests and questionnaires). EEG will be recorded during tests. A cheek swab will be performed. * Sessions S1 and S2. Perform several cognitive tasks while exposed to hypoxia and to normoxia (2 different sessions, randomized order) in a normobaric chamber. These are standardized cognitive tests administered on a computer and cognitive tests embedded in a flight simulator scenario. Various questionnaires will be performed on a regular basis. Several physiological measurements will be performed continuously: EEG, ECG, SpO2 and breathing rate. Blood pressure will be measured at the beginning and at the end of hypoxia/normoxia exposure. A blood sample will also be performed. At last, participants will inhale air or oxygen through a mask while making a cognitive task in the chamber.

Participants needed: 50
Trial details
Age: 18-45Biological sex: AllType: InterventionalSponsor: Direction Centrale du Service de Santé des ArméesUpdated: May 13, 2026Locations: 1
Eligibility criteria

Healthy volunteer [+1]

Individuals who do not understand French [+14]

Status: Recruiting

Effect of Acute Hypoxia on RIght VEntRicular Function in HAPE.

More and more people are engaging in sports in the mountains, including individuals with heart or lung diseases. At the same time, such diseases are becoming more common in Switzerland. At high altitude, less oxygen is available, which places stress on the body-particularly on the heart, which has to pump blood through the lungs. How the heart, especially the right ventricle, in people with past HAPE responds to this stress is still not well understood. Therefore, this study investigates how the heart responds to simulated altitudes of 2,500 m and 4,000 m, both at rest and during light physical activity in patients with past HAPE. The primary objective is to assess how right ventricular function changes under conditions of reduced oxygen availability. In addition, vital signs, changes in blood gases, oxygen levels in blood and tissue and shortness of breath are assessed. The "altitude" is simulated using a special gas mixture that participants inhale. Participants undergo three altitude conditions (490, 2,500, and 4,000 m above sea level). The order of the altitude conditions is assigned at random. The aim is to better understand how the right ventricle and other parameters respond to low-oxygen conditions and how affected patients can be better supported in the future.

Participants needed: 18
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Mona LichtblauUpdated: May 1, 2026Locations: 1
Eligibility criteria

Signed informed consent [+4]

<18, >80 years old [+7]

Status: Recruiting

Effect of Acute Hypoxia on RIght VEntRicular Function in Healthy Adults.

More and more people are engaging in sports in the mountains, including individuals with heart or lung diseases. At the same time, such diseases are becoming more common in Switzerland. At high altitude, less oxygen is available, which places stress on the body-particularly on the heart, which has to pump blood through the lungs. How the healthy heart, especially the right ventricle, responds to this stress is still not well understood. Therefore, this study investigates how the heart responds to simulated altitudes of 2,500 m and 4,000 m, both at rest and during light physical activity. The present investigation focuses on healthy individuals in order to establish a reference for future comparisons with patients suffering from cardiopulmonary diseases. The primary objective is to assess how right ventricular function changes under conditions of reduced oxygen availability. In addition, vital signs, changes in blood gases, oxygen levels in blood and tissue and shortness of breath are assessed. The "altitude" is simulated using a special gas mixture that participants inhale. Healthy participants undergo three altitude conditions (490, 2,500, and 4,000 m above sea level). The order of the altitude conditions is assigned at random. The aim is to better understand how the right ventricle and other parameters respond to low-oxygen conditions and how affected patients can be better supported in the future.

Participants needed: 18
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Mona LichtblauUpdated: Mar 17, 2026Locations: 2
Eligibility criteria

Signed informed consent [+2]

<18, >80 years old -Any diagnosed cardiopulmonary condition including past HAPE [+5]